Corrigendum re "Impact of Body Mass Index on Survival Outcomes for Patients with Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: A Systematic Review and Meta-analysis" [Eur Urol Open Sci 2022;39:62-71]
- PMID: 36583180
- PMCID: PMC9793202
- DOI: 10.1016/j.euros.2022.12.001
Corrigendum re "Impact of Body Mass Index on Survival Outcomes for Patients with Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: A Systematic Review and Meta-analysis" [Eur Urol Open Sci 2022;39:62-71]
Abstract
[This corrects the article DOI: 10.1016/j.euros.2022.03.002.].
© 2022 The Author(s).
Erratum for
-
Impact of Body Mass Index on Survival Outcomes of Patients with Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: A Systematic Review and Meta-analysis.Eur Urol Open Sci. 2022 Apr 4;39:62-71. doi: 10.1016/j.euros.2022.03.002. eCollection 2022 May. Eur Urol Open Sci. 2022. PMID: 35528786 Free PMC article.
Similar articles
-
Corrigendum re "Hypofractionated Postoperative Radiotherapy for Prostate Cancer: Is the Field Ready Yet?" [Eur Urol Open Sci 2020;22:9-16].Eur Urol Open Sci. 2022 Aug 27;44:52-53. doi: 10.1016/j.euros.2022.08.012. eCollection 2022 Oct. Eur Urol Open Sci. 2022. PMID: 36093321 Free PMC article.
-
Corrigendum to "Prognostic Expression Signature of RB1, PTEN, and TP53 Genes in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors" [Eur. Urol. Open Sci. 70 (2024) 86-90].Eur Urol Open Sci. 2025 Jun 4;77:31. doi: 10.1016/j.euros.2025.05.010. eCollection 2025 Jul. Eur Urol Open Sci. 2025. PMID: 40528940 Free PMC article.
-
Corrigendum re "Prostate-specific Membrane Antigen Positron Emission Tomography, Not Conventional Imaging, Should Be Performed for Primary Staging of High-risk Prostate Cancer" [Eur Urol Open Sci 2021;34:17-18].Eur Urol Open Sci. 2022 Apr 4;39:47. doi: 10.1016/j.euros.2022.03.008. eCollection 2022 May. Eur Urol Open Sci. 2022. PMID: 35403012 Free PMC article.
-
Corrigendum to "Rectal Perforation During Pelvic Surgery" [Eur Urol Open Sci 44 (2022) 54-59].Eur Urol Open Sci. 2023 Jan 20;49:10. doi: 10.1016/j.euros.2023.01.001. eCollection 2023 Mar. Eur Urol Open Sci. 2023. PMID: 36874597 Free PMC article.
-
First-line Treatment of Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: Systematic Review and Network Meta-analysis.Clin Genitourin Cancer. 2020 Aug;18(4):244-251.e4. doi: 10.1016/j.clgc.2020.02.012. Epub 2020 Mar 4. Clin Genitourin Cancer. 2020. PMID: 32303427
Publication types
LinkOut - more resources
Full Text Sources